Bridget Walsh is a proven Corporate Affairs leader with extensive experience leading government and public affairs teams for Fortune 500 healthcare companies. In these roles, she demonstrated the ability to mitigate risk by engaging with key stakeholders, developing and implementing strategies that protect and enhance organizational outcomes and reputations. She is adept at cultivating positive, credible and influential relationships with numerous stakeholders, including lawmakers, trade associations and national public policy groups. Bridget currently serves on the California Life Sciences Board of Directors.
Recently, she led Boehringer Ingelheim’s U.S. Government Relations and Public Policy group and headed its Washington, D.C. office. Boehringer Ingelheim is one of the top 20 biopharmaceutical companies in the world with 50,000 employees worldwide. The company develops not only human pharmaceuticals but also is the second largest company globally in the development and manufacturing of animal health medicines.
Bridget joined Boehringer Ingelheim in November 2017 from Pfizer where she was Vice-President of Federal Government Relations. Prior to Pfizer, Bridget served for 10 years on Capitol Hill including as Acting Chief of Staff, Deputy Chief of Staff and Legislative Director for Sen. Jon Tester and Deputy Legislative Director and Counsel for Sen. Bill Nelson.
Bridget’s experience included leading not only the legislative and fundraising activities of the Senators but also overseeing and supporting the messaging and communications teams, including as an on-the-record spokesperson for Sen. Nelson. Throughout her tenure on the Hill and in the private sector, she built strong relationships with both sides of the aisle and worked on federal campaigns.
Prior to her work on Capitol Hill, she was a senior litigation attorney in Chicago. Bridget is a graduate of the University of Notre Dame with a B.A. and the Loyola University of Chicago School of Law with a J.D. She is licensed to practice law in Illinois.
